These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 6137134

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P.
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG.
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Modifications in neurotransmission in degenerative dementia].
    Maloteaux JM.
    Acta Neurol Belg; 1989 Feb; 89(3-4):186-93. PubMed ID: 2576495
    [No Abstract] [Full Text] [Related]

  • 7. [Ageing and neurotransmitters].
    Nakamura S, Miyata S.
    Nihon Naika Gakkai Zasshi; 1985 Oct; 74(10):1348-52. PubMed ID: 2869092
    [No Abstract] [Full Text] [Related]

  • 8. Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
    Kish SJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O.
    Ann Neurol; 1985 Nov; 18(5):530-6. PubMed ID: 2416269
    [Abstract] [Full Text] [Related]

  • 9. Experimental pharmacology of Alzheimer disease.
    Greenwald BS, Davis KL.
    Adv Neurol; 1983 Nov; 38():87-102. PubMed ID: 6137135
    [Abstract] [Full Text] [Related]

  • 10. Biochemistry of Alzheimer's dementia.
    Marchbanks RM.
    J Neurochem; 1982 Jul; 39(1):9-15. PubMed ID: 6806445
    [No Abstract] [Full Text] [Related]

  • 11. Neurotransmitters and hypothalamic hormones in the central nervous system.
    Brownstein M.
    Fed Proc; 1977 Jun; 36(7):1960-3. PubMed ID: 16784
    [No Abstract] [Full Text] [Related]

  • 12. [Neurotransmitter abnormalities in the dementia of Alzheimer type].
    Sasaki H, Arai H.
    Rinsho Shinkeigaku; 1986 Dec; 26(12):1290-3. PubMed ID: 2881639
    [No Abstract] [Full Text] [Related]

  • 13. Alzheimer's disease and the new neuroscience.
    Wortis J.
    Biol Psychiatry; 1983 Aug; 18(8):847-8. PubMed ID: 6137248
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP.
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Significance of neurotransmitter abnormalities in Alzheimer's disease.
    Katzman R, Brown T, Fuld P, Thal L, Davies P, Terry R.
    Res Publ Assoc Res Nerv Ment Dis; 1986 Apr; 64():279-86. PubMed ID: 2873637
    [No Abstract] [Full Text] [Related]

  • 18. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders.
    Mann DM, Yates PO.
    Hum Neurobiol; 1986 Apr; 5(3):147-58. PubMed ID: 2876973
    [Abstract] [Full Text] [Related]

  • 19. [Dementia and neurotransmitters].
    Ishii T.
    Nihon Rinsho; 1984 Apr; 42(4):902-6. PubMed ID: 6148439
    [No Abstract] [Full Text] [Related]

  • 20. Cholinergic dysfunction in Alzheimer disease: cause or effect?
    Plotkin DA, Jarvik LF.
    Prog Brain Res; 1986 Apr; 65():91-103. PubMed ID: 2878469
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.